Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P020004/S205

GORE EXCLUDER AAA Endoprosthesis

W. L. Gore & Associates, Inc. · Decision date May 14, 2026

FDA DECISIONP020004/S205

What did the FDA approve?

FDA records P020004/S205 as a supplement to PMA P020004, with the supplement type “Real-Time Process”. The recorded decision is approval, dated May 14, 2026.

FDA approval order statement

Approval to remove a warning from the device labeling regarding lack of safety and effectiveness data on the use of your device in treatment of ruptured aneurysms, as well as a brief summary of the supportive data with regard to treatment of ruptured aneurysms.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
May 14, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P020004/S205
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
APPR
Decision date
May 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P020004/S201 · Related supplement

    EXCLUDER BIFURCATED ENDOPROSTHESIS

  2. P020004/S202 · Related supplement

    GORE EXCLUDER AAA Endoprosthesis

  3. P020004/S203 · Related supplement

    GORE EXCLUDER Iliac Branch Endoprosthesis

  4. P020004/S204 · Related supplement

    GORE EXCLUDER AAA Endoprosthesis and Iliac Branch Endoprosthesis

  5. P020004/S205 received

    Application receipt date recorded by FDA.

  6. P020004/S206 · Related supplement

    GORE EXCLUDER AAA Endoprosthesis; GORE EXCLUDER Iliac Branch Endoprosthesis

  7. P020004/S205 · FDA decision

    Real-Time Process

  8. P020004/S208 · Related supplement

    GORE EXCLUDER AAA Endoprosthesis

  9. P020004/S207 · Related supplement

    GORE EXCLUDER AAA Endoprosthesis; GORE EXCLUDER Iliac Branch Endoprosthesis

Timeline entries are records held by MedtechLedger for P020004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P020004

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

W. L. Gore & Associates, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
32360 N. N. Valley Pkwy., Phonix, AZ, 85085

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records